-
HUTCHMED Announces Enrollment Completed of SAFFRON Global Phase III Trial of ORPATHYS® and TAGRISSO® Combination for Certain Lung Cancer Patients with MET Overexpression and/or Amplification After Progression on TAGRISSO®
05 Nov 2025 00:00 GMT
… small cell lung cancer (“NSCLC”) following progression on treatment with TAGRISSO … SACHI randomized Phase III trial. ORPATHYS® is an oral … and Drug Administration (FDA) and enrollment was … any prescription drugs including the ones under development. CONTACTS
…
-
New treatments worsened disparities for lung cancer, melanoma
05 Nov 2025 00:16 GMT
… significantly following FDA approvals of immunotherapy.
Treatment innovations in advanced lung cancer and melanoma … be barriers to accessing these medications, including insurance, geographic location and … has maybe no copays for drugs that are shown to be …
-
Winners of the ASTRO-AstraZeneca Small Cell Lung Cancer Therapy Challenge Announced
04 Nov 2025 22:22 GMT
… 2025 ASTRO-AstraZeneca Small Cell Lung Cancer (SCLC) Therapy Challenge during its … Beckman Research Institute: “Phase II Trial of Stereotactic Ablative Radiation Therapy … one million Americans receive radiation treatments for their cancer each year …
-
Public Urged To Know Lung Cancer Signs And Reduce Risk
04 Nov 2025 15:40 GMT
… Health Agency (PHA) is using Lung Cancer Awareness Month (November) to remind … . Louise Herron, Consultant in Service Development and Screening at the PHA … , "finding lung cancer early improves the chances of successful treatment."
The …
-
Lung cancer isn’t just a smoker’s disease, say oncologists and warn on early signs this awareness month
04 Nov 2025 03:47 GMT
… , the greater their chance of developing lung cancer. But non-smokers aren’t … to reduce the risk of developing lung cancer?
"The most powerful step … be ignored, and no herbal remedy can reverse the DNA damage …
-
MEDICAL MONDAY: Lung Cancer Awareness Month, prevention and treatment
03 Nov 2025 21:03 GMT
… /WECP) - November is Lung Cancer Awareness Month.
Dr. Andrew Weber … to discuss prevention, resources, and treatment.
We also discussed the signs … the latest news as it develops, follow WJHG on Facebook, Instagram …
-
<![CDATA[Zocilurtatug Pelitecan Shows Potential in Small Cell Lung Cancer]]>
03 Nov 2025 15:46 GMT
… phase 1 (NCT06179069) clinical trial show that zocilurtatug pelitecan (formerly … for patients with small cell lung cancer (SCLC).1
Zocilurtatug pelitecan … untreated brain metastases requiring concurrent treatment, having leptomeningeal disease, and …
-
Can lung cancer cause pleural effusion and how do doctors diagnose it?
03 Nov 2025 13:22 GMT
… pleural effusion to return after treatment. According to Yale Medicine, … symptoms and advise on suitable treatments if it comes back.
… an existing lung cancer diagnosis and develop new or worsening symptoms.
Lung cancer is … and advise on suitable treatments.
-
Iovance Biotherapeutics Reports Potential Best-in-Class Clinical Data for Lifileucel TIL Cell Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
03 Nov 2025 12:00 GMT
… biotechnology company focused on innovating, developing, and delivering novel polyclonal … checkpoint inhibitor.” Following initial treatment with immune checkpoint inhibitor and … with the FDA regarding our non-small cell lung cancer clinical trials) and our …
-
LUNGevity Foundation Launches 2025 Lung Cancer Awareness Month with 60,000 White Flags on the National Mall in Washington DC
03 Nov 2025 11:24 GMT
… to screen for lung cancer, to fund research for improved treatments, and to … live with lung cancer. Through research that advances early detection and treatments, education … tools to find a clinical trial. All these programs are designed …
About
© 1995-2025